Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/1999

01-03-1999

Quality of life in patients with ductal carcinoma in situ of the breast treated with conservative surgery and postoperative irradiation

Authors: Maurizio Amichetti, Orazio Caffo, Mauro Arcicasa, Mario Roncadin, Ornella Lora, Alberto Rigon, Giampaolo Zini, Luciano Armaroli, Francesca Coghetto, Pierluigi Zorat, Stefanoti Neri, Nazario Teodorani

Published in: Breast Cancer Research and Treatment | Issue 2/1999

Login to get access
Metadata
Title
Quality of life in patients with ductal carcinoma in situ of the breast treated with conservative surgery and postoperative irradiation
Authors
Maurizio Amichetti
Orazio Caffo
Mauro Arcicasa
Mario Roncadin
Ornella Lora
Alberto Rigon
Giampaolo Zini
Luciano Armaroli
Francesca Coghetto
Pierluigi Zorat
Stefanoti Neri
Nazario Teodorani
Publication date
01-03-1999
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 2/1999
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1006125602353

Other articles of this Issue 2/1999

Breast Cancer Research and Treatment 2/1999 Go to the issue

OriginalPaper

Dose intensification of mitoxantrone in combination with paclitaxel in advanced breast cancer: a phase II study

OriginalPaper

Invasion marker PAI‐1 remains a strong prognostic factor after long‐term follow‐up both for primary breast cancer and following first relapse

OriginalPaper

Tumour necrosis factor‐α and interleukin‐1 and ‐6 in fibrocystic breast disease

OriginalPaper

De‐regulation of GRP stress protein expression in human breast cancer cell lines

OriginalPaper

The additionally glycosylated variant of human sex hormone‐binding globulin (SHBG) is linked to estrogen‐dependence of breast cancer

OriginalPaper

Vitamin D3 receptor (VDR) expression in HC‐11 mammary cells: regulation by growth‐modulatory agents, differentiation, and Ha‐ras transformation
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits